Zobrazeno 1 - 10
of 273
pro vyhledávání: '"M Salzer-Kuntschik"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
K. Winkler, G. Beron, R. Kotz, M. Salzer-Kuntschik, J. Beck, W. Beck, W. Brandeis, W. Ebell, R. Erttmann, U. Göbel, W. Havers, G. Henze, L. Hinderfeld, P. Höcker, A. Jobke, H. Jürgens, H. Kabisch, P. Preusser, G. Prindull, W. Ramach, J. Ritter, J. Sekera, J. Treuner, G. Wüst
Publikováno v:
Zeitschrift für Orthopädie und ihre Grenzgebiete. 124:22-29
Following preoperative chemotherapy of 9-18 weeks duration limb salvage procedures were performed instead of ablative surgery in about 1/2 of the patients (pts). Overall continuous disease-free survival rate is 69% (80/115) at 37 (21-51) months. 5 pt
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::726bc2c4c6658f74c90c099ba976c158
https://doi.org/10.1055/s-2008-1044518
https://doi.org/10.1055/s-2008-1044518
Autor:
Rainer Kotz, M. Salzer-Kuntschik, A. R. von Hochstetter, Volker Ewerbeck, N. Münchow, G. U. Exner, U. Heise, D. Schwenzer, Ulrich Göbel, K. Helmke, Rainer Maas, Jörn Treuner, M. Werner, Heribert Jürgens, Stefan S. Bielack, N. Fuchs, Norbert Graf, Günter Delling, U. Veltmann, T. Birkfellner, Andreas Zoubek, Beate Kempf-Bielack, W. Winkelmann
Publikováno v:
Klinische Pädiatrie. 211:260-270
BACKGROUND Owing to twenty years of multicentric interdisciplinary cooperation, the COSS group has been able to collect data on a large group of osteosarcoma patients treated by neoadjuvant therapy. This paper reviews results achieved in patients wit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::67599bf77231390373144c1fddc69e8d
https://doi.org/10.1055/s-2007-1019701
https://doi.org/10.1055/s-2007-1019701
Autor:
A Zoubek, C Pfleiderer, M Salzer-Kuntschik, G Amann, R Windhager, FM Fink, E Koscielniak, O Delattre, S Strehl, PF Ambros, H Gadner, H Kovar
Publikováno v:
British Journal of Cancer
Ewing tumours (ET), including Ewing's sarcoma and peripheral primitive neuroectodermal tumour, are well characterised at the molecular level by a unique chromosomal rearrangement which fuses the EWS gene to one of two closely related ETS proto-oncoge
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e038289dec0e55e4de5cc5b4ed83f897
https://doi.org/10.1038/bjc.1994.419
https://doi.org/10.1038/bjc.1994.419
Autor:
H. Kovar, A. Zoubek, C. Pfleiderer, G. Jug, A. Auinger, D. Aryee, P. Ambros, M. Salzer-Kuntschik, G. Amann, R. Windhager, H. Gadner
Publikováno v:
Klinische Pädiatrie. 206:196-200
The family of Ewing tumors (ET) is characterised by a unique gene rearrangement which is represented by a translocation t(11;22) (q24;q12) or a deletion del 22q12 in most cytogenetically analysable cases. The recent cloning of the underlying gene fus
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b08686b131285bed25d15c48be980c82
https://doi.org/10.1055/s-2008-1046605
https://doi.org/10.1055/s-2008-1046605
Autor:
P. Bieling, S. Bielack, G. Delling, H. Jürgens, R. Kotz, C. Dose, H. Astheimer, G. Exner, H. Gadner, N. Graf, J. Ritter, M. Salzer-Kuntschik, P. Weinel, K. Winkler
Publikováno v:
Klinische Pädiatrie. 203:220-230
The neoadjuvant study COSS-86 was undertaken aiming at (1) improving the cure rate in osteosarcoma by early intensification of chemotherapy in high risk patients and (2) investigating the effect of intraarterial (i.a.) versus intravenous (i.v.) admin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0c0be8b692eefdc20d512e8ee3970780
https://doi.org/10.1055/s-2007-1025433
https://doi.org/10.1055/s-2007-1025433
Autor:
M. Salzer-Kuntschik, J. Dunst, R. Kürten, Rolf Sauer, J. M. V. Burgers, W. Winkelmann, R. Hawliczek, H. Jürgens, M. Müschenich
Publikováno v:
Cancer. 67:2818-2825
The Cooperative Ewing's Sarcoma Studies, CESS 81 and CESS 86, are multiinstitutional trials with more than 80 participating institutions from Germany, the Netherlands, Austria, and Switzerland. Treatment consists of four courses of multiagent chemoth
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f211aa11afe5f7d49b941139805bdcae
https://doi.org/10.1002/1097-0142(19910601)67:11<2818::aid-cncr2820671118>3.0.co
https://doi.org/10.1002/1097-0142(19910601)67:11<2818::aid-cncr2820671118>3.0.co
Autor:
S, Bielack, B, Kempf-Bielack, D, Schwenzer, T, Birkfellner, G, Delling, V, Ewerbeck, G U, Exner, N, Fuchs, U, Göbel, N, Graf, U, Heise, K, Helmke, A R, von Hochstetter, H, Jürgens, R, Maas, N, Münchow, M, Salzer-Kuntschik, J, Treuner, U, Veltmann, M, Werner, W, Winkelmann, A, Zoubek, R, Kotz
Publikováno v:
Klinische Padiatrie. 211(4)
Owing to twenty years of multicentric interdisciplinary cooperation, the COSS group has been able to collect data on a large group of osteosarcoma patients treated by neoadjuvant therapy. This paper reviews results achieved in patients with localized
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::b81122456f69dafc4584ac910f291e2f
https://pubmed.ncbi.nlm.nih.gov/10472560
https://pubmed.ncbi.nlm.nih.gov/10472560
Autor:
M, Salzer-Kuntschik
Publikováno v:
Verhandlungen der Deutschen Gesellschaft fur Pathologie. 82
Osteoclast-like giant cells (GC) may dominate the histologic pattern not only in conventional giant-cell tumor (GCT)--originating as a radiologically pure lytic, possibly trabeculated lesion especially within the epiphyses of long tubular bones (LB)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::19a0ab39eec99f0f45edbca6a393db31
https://pubmed.ncbi.nlm.nih.gov/10095427
https://pubmed.ncbi.nlm.nih.gov/10095427
Autor:
N. Fuchs, Norbert Graf, Dieter Körholz, D Epler, M. Salzer-Kuntschik, Heribert Jürgens, Rainer Kotz, P. Weinel, G. Delling, P Bieling, Mathias Werner, K. Winkler, Stefan S. Bielack, U. Heise
Publikováno v:
Annals of oncology : official journal of the European Society for Medical Oncology. 9(8)
Summary Background: In an effort to intensify osteosarcoma therapy, systemic ifosfamide was added pre- and postoperatively to an already aggressive three-drug regimen. In a subgroup of patients, loco-regional treatment intensification was attempted b
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fc0d969d9966c97cfccd8f8cd65c030c
https://pubmed.ncbi.nlm.nih.gov/9789613
https://pubmed.ncbi.nlm.nih.gov/9789613